SYK vs XLI
Stryker Corporation (SYK) versus XLI (XLI) — a side-by-side from cached financials, not a winner call.
Stryker Corporation (SYK) is a medical devices company listed on NYSE.
XLI (XLI) common stock.
Latest reported SYK revenue for 2026-06-30 was $6.59B. Net income was $1.28B. Revenue was up 9.5% from 2026-03-31 to 2026-06-30. SYK currently screens at market cap $115.45B and trailing P/E 34.9.
XLI does not have a complete income-statement cache yet.
SYK currently screens at market cap $115.45B and trailing P/E 34.9. XLI currently screens at market cap $0.
Not investment advice. Open the SYK and XLI stock pages for the full models.
Not investment advice.